Segment and Geographic Information (Tables)

12 Months Ended

Dec. 31, 2013

Schedule of Segment Reporting Information, by Segment



	Year Ended December 31, 2013
	Energy & Chemicals		Distribution & Storage		BioMedical		Corporate			Total
Sales to external customers	$	318,510	$	592,616	$	266,312	$	—		$	1,177,438
Depreciation and amortization expense	8,564		15,237		14,618		1,970			40,389
Operating income (loss)	59,671		93,560		33,039		(50,273		)	135,997
Total assets ⁽¹⁾	277,760		676,484		431,763		75,623			1,461,630
Capital expenditures	34,194		32,039		3,370		2,982			72,585



	Year Ended December 31, 2012
	Energy & Chemicals		Distribution & Storage		BioMedical		Corporate			Total
Sales to external customers	$	323,676	$	475,576	$	214,900	$	—		$	1,014,152
Depreciation and amortization expense	7,877		12,599		10,204		1,516			32,196
Operating income (loss)	64,931		79,175		24,079		(46,372		)	121,813
Total assets ⁽¹⁾	203,044		607,252		447,792		69,753			1,327,841
Capital expenditures	9,519		30,048		2,717		1,401			43,685



	Year Ended December 31, 2011
	Energy & Chemicals		Distribution & Storage		BioMedical		Corporate			Total
Sales to external customers	$	205,033	$	390,332	$	199,220	$	—		$	794,585
Depreciation and amortization expense	7,417		11,767		7,588		1,143			27,915
Operating income (loss)	27,489		61,415		35,911		(34,821		)	89,994
Total assets ⁽¹⁾	203,067		556,688		226,729		187,991			1,174,475
Capital expenditures	5,228		7,808		6,692		2,652			22,380

_______________


⁽¹⁾	Corporate assets consist primarily of cash, cash equivalents and deferred income taxes.

Schedule of Goodwill [Table Text Block]

The following table represents the changes in goodwill:



	December 31,
	2013			2012
Beginning balance	$	398,941		$	288,770
Foreign currency translation adjustments and other	(344		)	408
Goodwill acquired during the year	308			109,763
Ending balance	$	398,905		$	398,941

The following table represents the changes in goodwill by segment:



	Energy & Chemicals		Distribution & Storage		BioMedical			Total
Balance at January 1, 2012	$	83,215	$	158,381	$	47,174		$	288,770
Foreign currency translation adjustments and other	—		408		—			408
Goodwill acquired during the year	—		—		109,763			109,763
Balance at December 31, 2012	83,215		158,789		156,937			398,941
Foreign currency translation adjustments and other	—		957		(1,301		)	(344		)
Goodwill acquired during the year	—		308		—			308
Balance at December 31, 2013	$	83,215	$	160,054	$	155,636		$	398,905

Reconciliation of Revenue from Segments to Consolidated



	Year Ended December 31,
	2013		2012		2011
Energy & Chemicals
Heat exchangers – Brazed aluminum	$	170,104	$	146,110	$	92,013
Heat exchangers – Air cooled	54,275		69,977		66,962
Cold boxes	94,131		107,589		46,058
Energy & Chemicals Total	318,510		323,676		205,033
Distribution & Storage
Cryogenic bulk storage systems	175,123		153,372		153,518
Cryogenic packaged gas systems and beverage liquid CO₂ systems	152,922		143,548		142,262
LNG applications	193,032		107,231		35,678
Cryogenic systems, components and services	71,539		71,425		58,874
Distribution & Storage Total	592,616		475,576		390,332
BioMedical
Medical respiratory products	175,233		143,878		138,411
Biological storage systems	61,493		64,449		60,809
On-site oxygen generation systems	29,586		6,573		—
BioMedical Total	266,312		214,900		199,220
Total	$	1,177,438	$	1,014,152	$	794,585

Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas



	Sales for the Year Ended December 31,
	2013		2012		2011
United States	$	479,067	$	438,294	$	334,517
China	231,143		149,010		92,142
Rest of World	467,228		426,848		367,926
Total	$	1,177,438	$	1,014,152	$	794,585



	Property, plant and equipment, net as of December 31,
	2013		2012		2011
United States	$	146,610	$	98,425	$	75,848
Czech Republic	23,623		21,559		21,805
China	38,569		34,158		23,410
Germany	14,618		14,402		14,672
Other foreign countries	785		1,232		1,566
Total	$	224,205	$	169,776	$	137,301

- Definition

Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.

+ References+ Details